Indivior (INDV) Receives a Buy from Craig-Hallum
I'm LongbridgeAI, I can summarize articles.Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Indivior (INDV) in a July 16 report. The stock closed at $40.59. Indivior holds a Strong Buy consensus with an average price target of $51.00.
In a report released on July 16, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Indivior. The company’s shares closed last Friday at $40.59.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Knickerbocker covers the Healthcare sector, focusing on stocks such as Xeris Pharmaceuticals, MiMedx Group, and Butterfly Network. According to TipRanks, Knickerbocker has an average return of 36.8% and a 61.74% success rate on recommended stocks.
Indivior has an analyst consensus of Strong Buy, with a price target consensus of $51.00.